DLA
ELAN icon

Douglas Lane & Associates’s Elanco Animal Health ELAN Stock Holding History

Douglas Lane & Associates’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$50.2M Sell
3,512,675
-382,515
-10% -$5.46M 0.73% 57
2025
Q1 		$40.9M Buy
3,895,190
+205,241
+6% +$2.16M 0.6% 67
2024
Q4 		$44.7M Sell
3,689,949
-77,835
-2% -$943K 0.63% 67
2024
Q3 		$55.3M Buy
3,767,784
+37,349
+1% +$549K 0.76% 52
2024
Q2 		$53.8M Sell
3,730,435
-179,025
-5% -$2.58M 0.76% 52
2024
Q1 		$63.6M Sell
3,909,460
-17,770
-0.5% -$289K 0.9% 49
2023
Q4 		$58.5M Sell
3,927,230
-40,591
-1% -$605K 0.9% 48
2023
Q3 		$44.6M Buy
3,967,821
+889,295
+29% +$10M 0.75% 53
2023
Q2 		$31M Buy
3,078,526
+613,580
+25% +$6.17M 0.5% 74
2023
Q1 		$23.2M Buy
2,464,946
+286,222
+13% +$2.69M 0.39% 90
2022
Q4 		$26.6M Sell
2,178,724
-243,610
-10% -$2.98M 0.45% 82
2022
Q3 		$30.1M Sell
2,422,334
-131,151
-5% -$1.63M 0.56% 71
2022
Q2 		$50.1M Buy
2,553,485
+57,964
+2% +$1.14M 0.85% 46
2022
Q1 		$65.1M Buy
2,495,521
+135,410
+6% +$3.53M 0.92% 41
2021
Q4 		$67M Buy
2,360,111
+118,101
+5% +$3.35M 0.89% 43
2021
Q3 		$71.5M Buy
2,242,010
+61,322
+3% +$1.96M 1.02% 32
2021
Q2 		$75.6M Buy
2,180,688
+454,605
+26% +$15.8M 1.06% 36
2021
Q1 		$50.8M Buy
1,726,083
+421,004
+32% +$12.4M 0.79% 52
2020
Q4 		$40M Buy
1,305,079
+114,455
+10% +$3.51M 0.67% 58
2020
Q3 		$33.3M Buy
1,190,624
+267,580
+29% +$7.47M 0.66% 56
2020
Q2 		$19.8M Buy
923,044
+313,332
+51% +$6.72M 0.43% 78
2020
Q1 		$13.7M Buy
609,712
+489,240
+406% +$11M 0.36% 84
2019
Q4 		$3.55M Buy
+120,472
New +$3.55M 0.07% 112